HF Collaboratory Organizational Chart

RESEARCH NETWORKS/SOCIETIES

Christopher O’Connor, MD, MACC, FESC, FHFSA
CEO and Executive Director, Inova Heart & Vascular
Institute
Professor of Medicine
Duke University

David Whellan, MD, FACC, FHFSA
James C. Wilson Professor of Medicine
Associate Provost for Clinical Research, Thomas
Jefferson University
Associate Dean for Clinical Research, Sidney
Kimmel Medical College
Executive Director, Jefferson Clinical Research
Institute

Tomas Andersson, MD
Vice President, Medical Science Director
AstraZeneca

Michael Bristow, MD, PhD, FACC, FHFSA
Professor of Medicine (Cardiology)
Director of Pharmacogenomics
University of Colorado Division of Cardiology
President and CEO, ARCA Biopharma

Cynthia Chauhan
Patient Representative

Robert Cole, MD, FACC
Director of Heart Failure
Inova Heart & Vascular Institute

Christophe Depre, MD, PhD
Medical Fellow, Early Phase Clinical R&D, Diabetes and Complications
Eli Lilly and Company

Patrice Desvigne-Nickens, MD (NIH/NHLBI)
Medical Officer, Heart Failure and Arrhythmias
Division of Cardiovascular Sciences

Jay Edelberg, MD, PhD
Senior Vice President – Clinical Development
MyoKardia

Mona Fiuzat, PharmD, FACC, FHFSA, FHFA
Senior Scientific Advisor, Division of Cardiovascular
and Renal Products
U.S. Food and Drug Administration
Associate Professor of Medicine
Duke University School of Medicine

Rachel Lindstrom, MD
Medical Director
Amgen

Fady Malik, MD, PhD
Executive Vice President
Research and Development

Robert Mentz, MD, FACC, FHFSA
Advanced Heart Failure Specialist, Cardiologist,
Hearth Transplant Specialist
Associate Professor of Medicine
Associate Professor in Population Health Sciences
Duke Clinical Research Institute

Mitchell Psotka, MD, PhD
Advanced Heart Failure, Transplant, and
Pulmonary Hypertension
Associate Director Heart Failure Site Based
Research
Associate Director Heart Failure Outreach
Inova Heart & Vascular Institute

Mary N. Walsh, MD, FACC, FHFSA
Medical Director, Heart Failure and
Transplantation Director, Nuclear Cardiology
St. Vincent Heart Center

REPRESENTATIVE POPULATIONS

JoAnn Lindenfeld, MD, FACC, FAHA, FHFSA
Director, Heart Failure and Transplant Program
Professor of Medicine
Vanderbilt University

Muthiah Vaduganathan, MD
Fellow in Cardiovascular Medicine,
Brigham and Women’s Hospital Heart and Vascular
Center and Harvard Medical School

Orly Vardeny, PharmD, MS, FHFSA
Associate Professor of Pharmacy and Medicine
University of Minnesota

Phillip Adamson, MD, MSc, FACC
Medical Director and Divisional Vice President
Abbott

Lawton Cooper, MD (NIH/NHLBI)
Medical Officer, Heart failure/Care delivery/Afib
National Heart, Lung, and Blood Institute

Lauren Cooper, MD, MHS, FACC, FHFSA
Director of Heart Failure Disease Management
Clinic
Associate Director of Heart Failure Research
Inova Heart & Vascular Institute

Piper Dankworth
Patient Representative

Melvin Echols, MD
Assistant Professor of Medicine
Morehouse School of Medicine

Mona Fiuzat, PharmD, FACC, FHFSA, FHFA
Senior Scientific Advisor, Division of Cardiovascular
and Renal Products
U.S. Food and Drug Administration
Associate Professor of Medicine
Duke University School of Medicine

John Godwin
Patient Representative

Mariell Jessup, MD, FACC, FAHA, FHFA
Emeritus Professor of Medicine
University of Pennsylvania
Chief Science and Medical Officer
American Heart Association

Dalane Kitzman, MD, FACC
Professor of Medicine
Wake Forest Baptist Medical Center

Ralph Knoell, MD
Chief Scientist
AstraZeneca

Eric Leifer, PhD (NIH/NHLBI)
Mathematical Statistician
Office of Biostatistics Research
National Heart, Lung, and Blood Institute

Martin Mendoza, PhD
Director, Extramural Research Program
Office of Minority Health
US Food and Drug Administration

Christopher O’Connor, MD, MACC, FESC, FHFSA
CEO and Executive Director, Inova Heart & Vascular
Institute
Professor of Medicine
Duke University

Ileana Pina, MD
Professor of Medicine, Epidemiology/Population
Health
Albert Einstein College of Medicine
Associate Chief, Cardiology
Senior Staff Fellow and Medical Reviewer
Center for Devices and Radiological Health
U.S. Food and Drug Administration

Mitchell Psotka, MD, PhD
Advanced Heart Failure, Transplant, and
Pulmonary Hypertension
Associate Director Heart Failure Site Based
Research
Associate Director Heart Failure Outreach
Inova Heart & Vascular Institute

Fortunato (Fred) Senatore MD, PhD, FACC
Medical Officer
Division of Cardiovascular and Renal Products
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Kenneth Stein, MD
Senior Vice President and Chief Medical Officer
for Rhythm Management
and Global Health Policy
Boston Scientific

Laura Williams
Patient Representative

Clyde Yancy, MD, MSc, MACC, FAHA, FHFSA
Vice Dean for Diversity and Inclusion
Chief of Cardiology, Department of Medicine
Northwestern Feinberg School of Medicine

Ersilia M. DeFilippis, MD

Internal medicine resident at Brigham and Women’s Hospital

DIGITAL HEALTH

Tariq Ahmad, MD, FACC
Advanced Heart Failure and Transplant
Assistant Professor of Medicine
Yale New Haven Health System

Robert Harrington, MD, MACC, FAHA, FESC
Arthur L. Bloomfield Professor
Chair, Department of Medicine
Stanford University

Mitchell Psotka, MD, PhD
Advanced Heart Failure, Transplant, and
Pulmonary Hypertension
Associate Director Heart Failure Site Based
Research
Associate Director Heart Failure Outreach
Inova Heart & Vascular Institute

Mona Fiuzat, PharmD, FACC, FHFSA, FHFA
Senior Scientific Advisor, Division of Cardiovascular
and Renal Products
U.S. Food and Drug Administration
Associate Professor of Medicine
Duke University School of Medicine

David Kao, MD, FACC
Assistant Professor of Medicine
Divisions of Cardiology and
Bioinformatics/Personalized Medicine
University of Colorado

Harlan Krumholz, MD, SM, FACC
Harold H. Hines, Jr. Professor of Medicine
Professor in the Institute for Social and Policy
Studies
Director, Center for Outcomes Research and
Evaluation
Yale University

Elizabeth Kunkoski, MS
Biomedical Engineer
US Food and Drug Administration Drug Administration

Maulik Majmudar, MD
Medical Officer, Amazon

Christopher O’Connor, MD, MACC, FESC, FHFSA
CEO and Executive Director, Inova Heart & Vascular
Institute
Professor of Medicine
Duke University

Jonathan Fox, MD, PhD, FACC
President and CMO
Eidos Therapeutics, Inc.

Richard Nkulikiyinka, MD
Head of TA Cardiology & Nephrology
Bayer AG, R& D, Pharmaceuticals

Magnus Petersson, MD
Global Clinical Lead
AstraZeneca

Jerome Riebman, MD, MA
US Medical Lead, Heart Failure | US Medical Lead, Pipeline Products
Amgen

Kuldeep Rajput, PhD
Founder & CEO
Biofourmis

Leonard Sacks, MD
Associate Director for Clinical Methodology
Office of Medical Policy
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Joel Selcher, PhD
Vice President, Regulatory
MyoKardia

Abhinav Sharma, MD, FRCPC, ABIM
Physician, Advanced Heart Failure and Cardiac
Transplant Specialist
Mazankowski Heart Institute

Whit Tingley, MD, PhD
Chief Medical Officer
Tenaya Therapeutics

Benoit Tyl, MD
Translational & Clinical Research Director
Servier

Paul Varghese, MD
Head, Health Informatics at Verily
Google Life Sciences

DEVICES

William Abraham, MD, FACP, FACC
Professor of Medicine
Associate Dean for Clinical Research
Director, Clinical Trials Management Office
Deputy Director, Davis Heart and Lung Research
Institute
Ohio State University

Robert Kazmierski, MD
Lead Reviewer
Center for Devices and Radiological Health
U.S. Food and Drug Administration

Amrut V. Ambardekar, MD
Medical Director Cardiac Transplant Program
Director of Clinical Research
Division of Cardiology, University of Colorado

Seth Bilazarian, MD
Chief Medical Officer
Abiomed

Peter Carson, MD, FACC
Clinical Professor of Medicine, MedSTAR
Georgetown
University Director, Heart Failure program
Washington
VA Medical Center

Mona Fiuzat, PharmD, FACC, FHFSA, FHFA
Senior Scientific Advisor, Division of Cardiovascular
and Renal Products
U.S. Food and Drug Administration
Associate Professor of Medicine
Duke University School of Medicine

Albert Gianchetti
CEO
XyloCor Therapeutics

Richard Jacob
Patient Representative

JoAnn Lindenfeld, MD, FACC, FAHA, FHFSA
Director, Heart Failure and Transplant Program
Professor of Medicine
Vanderbilt University

Christopher O’Connor, MD, MACC, FESC, FHFSA
CEO and Executive Director, Inova Heart & Vascular
Institute
Professor of Medicine
Duke University

Mitchell Psotka, MD, PhD
Advanced Heart Failure, Transplant, and
Pulmonary Hypertension
Associate Director Heart Failure Site Based
Research
Associate Director Heart Failure Outreach
Inova Heart & Vascular Institute

Joseph Rogers, MD, FACC, FHFSA
Professor of Medicine
Division of Cardiology
Chief Medical Officer, DUHS
Duke University School of Medicine

Dan Schaber, MD
Vice President of Heart Failure Clinical Research
Medtronic

Meir Shinnar, MD PhD
Medical Officer, Circulatory Support Device Branch,
Division of
Cardiac Devices, Office of Device Evaluation, Center
for Devices
and Radiological Health
U.S. Food and Drug Administration

Patrick Verta, MS Stat, DVM, MD
Vice President, Clinical Science and Biometrics
Transcatheter Mitral and Tricuspid Therapies
Edwards Lifesciences

Emily Zeitler, MD, MHS
Assistant Professor of Medicine
Cardiac Electrophysiology
Dartmouth-Hitchcock Medical Center
Geisel School of Medicine

Bram Zuckerman, MD
Director, FDA Division of Cardiovascular Devices
Center for Devices and Radiological Health
U.S. Food and Drug Administration

DRUGS

Marvin A. Konstam, MD, FACC, FHFSA
Chief Physician Executive
The CardioVascular Center
Professor of Medicine
Tufts University School of Medicine

Scott Solomon, MD, FACC, FHFSA
The Edward D. Frohlich Distinguished Chair
Professor of Medicine, Harvard Medical School
Director, Noninvasive Cardiology
Brigham and Women’s Hospital

Ellis Unger, MD
Director, Office of Drug Evaluation-I
Office of New Drugs
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Martina Brueckmann, MD
Global Head Heart Failure Clinical Development
Therapeutic Area Cardiometabolism
Boehringer Ingelheim

Javed Butler, MD, MPH, MBA, FACC, FHFSA
Chair of the Department of Medicine
University of Mississippi Medical Center

Chris Cabell, MD
Senior Vice President Clinical Development
Arena Pharmaceuticals

Graziella Collu, MD
Vice President, Global Regulatory, CVMD&NS
AstraZeneca

Mary DeSouza, MBA, PhD
Executive Director/Development Lead
Bristol-Myers Squibb

Peter DiBattiste, MD
Global Development Head, Cardiovascular
Janssen Pharmaceuticals

Michael Felker, MD, FACC, FHFSA
Chief of the Heart Failure Section
Professor of Medicine
Duke University

Mona Fiuzat, PharmD, FACC, FHFSA, FHFA
Senior Scientific Advisor, Division of Cardiovascular
and Renal Products
U.S. Food and Drug Administration
Associate Professor of Medicine
Duke University School of Medicine

Joerg Koglin, MD
Associate Vice President, Cardiovascular Clinical
Development
Merck

Martin Lefkowitz, MD
Vice President and Therapeutic Area Head
Novartis

Christopher O’Connor, MD, MACC, FESC, FHFSA
CEO and Executive Director, Inova Heart & Vascular
Institute
Professor of Medicine
Duke University

Mitchell Psotka, MD, PhD
Advanced Heart Failure, Transplant, and
Pulmonary Hypertension
Associate Director Heart Failure Site Based
Research
Associate Director Heart Failure Outreach
Inova Heart & Vascular Institute

Lothar Roessig, MD
Global Clinical Leader
Bayer

Steven Simonson, MD
Senior Vice President
Chief Medical Officer
Windtree Therapeutics, Inc.

Shashank Sinha, MD, MSc
Advanced Heart Failure & Transplant
Inova Heart & Vascular Institute

Norman Stockbridge, MD, PhD
Director, Division of Cardiovascular and Renal
Products
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

John Teerlink, MD, FACC, FHFSA
Director, Heart Failure Program and Clinical
Echocardiography Lab,
San Francisco VAMC
Professor of Clinical Medicine
University of California, San Francisco